These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33775354)

  • 1. Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center.
    Yuksel H; Gursoy GT; Dirik EB; Kenar SG; Bektas H; Yamanel L; Guner HR
    J Clin Neurosci; 2021 Apr; 86():97-102. PubMed ID: 33775354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.
    Amanat M; Rezaei N; Roozbeh M; Shojaei M; Tafakhori A; Zoghi A; Darazam IA; Salehi M; Karimialavijeh E; Lima BS; Garakani A; Vaccaro A; Ramezani M
    BMC Neurol; 2021 Mar; 21(1):116. PubMed ID: 33726699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Observational Study of Neurological Manifestations in COVID-19 (SON-CoV).
    Ramrakhiani N; Bhutani N; Chaudhary D; Parab P; Singh K; Agrawal P; Gupta V
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological manifestations in patients with severe COVID-19 in a tertiary care center].
    Albarran-Sanchez A; Noyola-García ME; Calderón-Vallejo A; Guízar-García LA; Rosales-Dueñas FJ; Barrientos-Flores CJ; Segura-Mendez NH; Herrera-Sánchez DA; Cuevas-García C
    Rev Med Inst Mex Seguro Soc; 2021 Nov; 59(6):545-550. PubMed ID: 34910416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Neurological Manifestations of COVID-19 Data from a Tertiary Care Hospital.
    Dias AL; Raghavendra BS; Ahmed S; Arunachalam R
    Neurol India; 2022; 70(5):1901-1904. PubMed ID: 36352585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Manifestations and Their Effect on Outcome in Second Wave of COVID-19 Pandemic: A Retrospective Cohort Study.
    Muley A; Mitra S; Bhojani H; Bavishi A; Nakum D; Kotwani P; Patwardhan V; Shah J; Mahendru S
    J Assoc Physicians India; 2022 Sep; 70(9):11-12. PubMed ID: 36082880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C.
    Fink EL; Robertson CL; Wainwright MS; Roa JD; Lovett ME; Stulce C; Yacoub M; Potera RM; Zivick E; Holloway A; Nagpal A; Wellnitz K; Czech T; Even KM; Brunow de Carvalho W; Rodriguez IS; Schwartz SP; Walker TC; Campos-Miño S; Dervan LA; Geneslaw AS; Sewell TB; Pryce P; Silver WG; Lin JE; Vargas WS; Topjian A; Alcamo AM; McGuire JL; Domínguez Rojas JA; Muñoz JT; Hong SJ; Muller WJ; Doerfler M; Williams CN; Drury K; Bhagat D; Nelson A; Price D; Dapul H; Santos L; Kahoud R; Francoeur C; Appavu B; Guilliams KP; Agner SC; Walson KH; Rasmussen L; Janas A; Ferrazzano P; Farias-Moeller R; Snooks KC; Chang CH; Yun J; Schober ME;
    Pediatr Neurol; 2022 Mar; 128():33-44. PubMed ID: 35066369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
    García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D;
    J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
    Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
    Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
    Wang L; Shen Y; Li M; Chuang H; Ye Y; Zhao H; Wang H
    J Neurol; 2020 Oct; 267(10):2777-2789. PubMed ID: 32529575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.
    Cleret de Langavant L; Petit A; Nguyen QTR; Gendre T; Abdelhedi J; Djellaoui A; Seddik L; Lim L; Faugeras F; Salhi H; Wahab A; Fechtenbaum L; Dormeuil A; Hosseini H; Youssov K; Fénelon G; Bapst B; Brugières P; Tuilier T; Kalsoum E; Matignon MB; Oniszczuk J; Gallien S; Vindrios W; Melica G; Scain AL; Esser R; Rostain L; Guillaud C; Dubos-Lascu G; Saada N; Guillet H; Khellaf M; Bardel B; Ayache SS; Lefaucheur JP; Pawlotsky JM; Fourati S; Bachoud-Lévi AC
    Rev Neurol (Paris); 2021 Mar; 177(3):275-282. PubMed ID: 33610347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Philippine
    Espiritu AI; Sy MCC; Anlacan VMM; Jamora RDG
    BMJ Open; 2020 Nov; 10(11):e040944. PubMed ID: 33257488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
    Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
    Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of fatal neurological complications among admitted COVID-19 patients with their implication in outcome: A Case Control study.
    Aslam J; Luqman S; Nazly S; Saeed A; Tariq MS; Alfaife SYM; Aneela I
    PLoS One; 2022; 17(9):e0274485. PubMed ID: 36156595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.